Drug Regulator Approves Wegovy as First GLP-1 for Adults with Fatty Liver Disease

Medicine

17 July 2026 at 9:17 pm

Drug Regulator Approves Wegovy as First GLP-1 for Adults with Fatty Liver Disease

News Studio

Summary

Wegovy has been approved by the drug regulator as the first GLP-1 medication for adults suffering from fatty liver disease.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from AI News Studio.

News Studio iconFAQ

Newsroom FAQs

About the public News Studio news feed powered by NewsEngine.